Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Lilly enters into new TB research partnership

Lilly enters into new TB research partnership

30th September 2009

Lilly has entered into a partnership with Academia Sinica which will see the foundation contribute to the company’s Tuberculosis (TB) Drug Discovery Initiative.

The memorandum of understanding was signed this week and will lead to the organisations cooperating on target-based screening for the discovery of new TB cases.

Other foundations that have participated in the initiative include the Infectious Disease Research Institute and the National Institute of Allergy and Infectious Diseases.

Gail Cassell, Lilly’s vice-president of scientific affairs, stated: “To have Dr Chi-Huey Wong, president of Academia Sinica and one of the most outstanding chemists in the world, on our steering committee will provide invaluable guidance to our efforts.”

The treatment of TB requires a combination of various drugs, which makes research and development integral to controlling the condition.

Lilly recently revealed that its has reshuffled its ranks and appointed various figures as new department heads, including Tim Garnett and Tom Verhoeven, who will jointly lead its Development Centre of Excellence.

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.